Clinical Trial Research
Neuroscience Group participates in clinical trial research to continually move treatments of complex conditions forward.
Learn About Clinical Trial Research at Neuroscience Group
Frequently Asked Questions about Clinical Trial Research
What are clinical trials?
Clinical trials are integral to medical advancement. These studies test new ways to prevent, detect, diagnose, or treat diseases and their goal is to determine if the new test or treatment is safe.
Who gets to be in a study?
Each research study is different. Each study tries to find answers to a specific question. Researchers must follow strict rules to decide who may take part in research. Not everyone with the disease or problem that is being studied can take part in a research study. If your doctor thinks that you might qualify for a study, he or she may ask if you want to take part.
Does Neuroscience Group participate in clinical trials?
We are currently participating in clinical trials specific to Migraine and Multiple Sclerosis. We hope to have the opportunity to participate in trials for other conditions as well.
How can I participate in a clinical trial?
Speak with your provider to see if you may qualify for a current study or call our Clinical Research Coordinator at 920-725-9373 ext 8003 for more information.
Are clinical trials safe?
The FDA works to protect participants in clinical trials and ensure that people have reliable information as they decide whether to join a clinical trial. The federal government has regulations and guidelines for clinical research to protect participants from unreasonable risks. Although efforts are made to control the risks to clinical trial participants, some risks may be unavoidable because of the uncertainty inherent in medical research studies involving new medical treatments.
What should I think about before joining a clinical trial?
People should learn as much as possible about the clinical trials that interest them. They should also feel comfortable discussing their questions and concerns with member of their health care team. Prospective participants should understand what happens during the trial, the type of health care they will receive and any costs to them—which may or may not include the cost of the product and costs associated with administering the product.
